Jafron Biomedical Co. Ltd. logo

Jafron Biomedical Co. Ltd. (300529)

Market Open
10 Aug, 06:57
XSHE XSHE
¥
16. 41
+0.03
+0.1832%
¥
16.2B Market Cap
- P/E Ratio
3.2% Div Yield
16.75M Volume
- Eps
¥ 16.38
Previous Close
Add Transaction
Day Range
16.2 16.88
Year Range
14.73 24.66
Want to track 300529 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

300529 trading today higher at ¥16.41, an increase of 0.1832% from yesterday's close, completing a monthly increase of 6.4893% or ¥1. Over the past 12 months, 300529 stock lost -16.531%.
300529 pays dividends to its shareholders, with the most recent payment made on Jun 01, 2026. The next estimated payment will be in In 9 months on Jun 01, 2027 for a total of ¥0.52.
The last earnings report, released on Apr 28, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.1128%, based on the last three reports.
Jafron Biomedical Co. Ltd. has completed 1 stock splits, with the recent split occurring on May 20, 2020.
The company's stock is traded on one exchange.

300529 Chart

People also search for

Aier Eye Hospital Group Co. Ltd.
¥ 9.05
-0.2205%
Haisco Pharmaceutical Group Co., Ltd.
¥ 70.17
-0.1565%
Shannon Semiconductor Tech Inc.
¥ 155.64
-0.6384%
Sichuan Kelun Pharmaceutical Co., Ltd.
¥ 47.33
+1.9823%
Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
¥ 27.47
-0.5431%

Jafron Biomedical Co. Ltd. (300529) FAQ

What is the stock price today?

The current price is ¥16.41.

On which exchange is it traded?

Jafron Biomedical Co. Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 300529.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 3.2%.

What is its market cap?

As of today, the market cap is 16.2B.

Has Jafron Biomedical Co. Ltd. ever had a stock split?

Jafron Biomedical Co. Ltd. had 1 splits and the recent split was on May 20, 2020.

Jafron Biomedical Co. Ltd. Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Mr. Fan Dong CEO
XSHE Exchange
CNE100002995 ISIN
CN Country
2,797 Employees
1 Jun 2026 Last Dividend
20 May 2020 Last Split
- IPO Date

Overview

Jafron Biomedical Co., Ltd. is a pioneering enterprise specializing in the domain of blood purification technologies. Established in 1989 and headquartered in Zhuhai, China, the company has dedicated itself to the research, development, production, and international sales of blood purification products within the hemadsorption industry. It addresses a broad spectrum of medical needs, ranging from End-Stage Renal Disease (ESRD) and acute poisoning to critical illnesses, liver disorders, immunological dysfunctions, and kidney and liver diseases. Jafron Biomedical has carved a niche for itself on a global scale, signifying its contribution to advancing medical treatment and patient care.

Products and Services

Jafron Biomedical Co.,Ltd. offers an array of specialized products and services catered towards improving patient outcomes in multiple medical scenarios. Each of these offerings is designed with the latest advancements in medical technology and research:

  • HA series hemoperfusion cartridge - A cornerstone product for the company, these cartridges are used in hemoperfusion therapy to remove harmful substances from the blood. They are applicable in treating a variety of conditions, including certain systemic toxicities and specific organ failures.
  • BS bilirubin adsorption column - Specifically designed for patients suffering from liver diseases, the BS bilirubin adsorption column helps in effectively lowering bilirubin levels in the blood, offering a critical supportive treatment in cases of severe jaundice and hepatic disorders.
  • DNA immunoadsorption column - This cutting-edge product targets autoimmune and immunological disorders by selectively removing pathogenic autoantibodies and immune complexes from the blood, thus providing a novel approach to treating these challenging conditions.
  • Hemoperfusion machine - Tailored to facilitate hemoperfusion treatment, this machine accurately and efficiently controls the blood purification process, ensuring the effective elimination of toxic substances from the blood.
  • Blood purification machine - A versatile device that supports various blood purification therapies, including hemoperfusion and dialysis, to treat a range of critical conditions by removing waste products and excess fluids from the blood.
  • Other products include a gamut of ancillary medical supplies such as hemodialyzers, hemodialysis concentrates, disinfectants, resin bandages, online hemodialysis powder bag/bucket, and absorbable sutures with needles. These products complement the company's primary offerings, ensuring a comprehensive approach to patient care and treatment.

Contact Information

Address: No. 98 Technology Six Road, Zhuhai, China, 519085
Phone: 86 75 6368 9708